Analysts have been eager to weigh in on the Healthcare sector with new ratings on Qiagen (QGEN – Research Report), Alcon (ALC – Research Report) and Nyxoah (NYXH – Research Report). Qiagen (QGEN) Kepler Capital analyst Maja Pataki maintained a Hold rating on Qiagen on August 10 and set a price target of EUR50.00. The company's shares closed last Thursday at $49.78. According to TipRanks.com, Pataki is ranked #7900 out of 8014 analysts. Currently, the analyst consensus on Qiagen is a Moderate Buy with an average price target of $48.01, implying a -4.5% downside from current levels.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-qiagen-qgen-alcon-alc-and-nyxoah-nyxh?utm_source=advfn.com&utm_medium=referral
Qiagen NV (NYSE:QGEN)
Historical Stock Chart
From Sep 2022 to Oct 2022 Click Here for more Qiagen NV Charts.
Qiagen NV (NYSE:QGEN)
Historical Stock Chart
From Oct 2021 to Oct 2022 Click Here for more Qiagen NV Charts.